• Login
Upgrade
JStories
  • 日本語
  • 中文 (中国)
No Result
View All Result
  • Home
  • AI
    • Artificial Intelligence
    • Robotics
    • Mobility
    • FinTech
    • Quantum
  • Earth
    • AgriTech
    • Green Innovation
    • Disaster Tech
    • SpaceTech
    • Materials
  • Life Sciences
    • BioTech
    • HealthTech
    • MedTech
    • AgeTech
  • Society
    • Media
    • EdTech
    • Diversity
    • FemTech
    • Social Impact
  • Lifestyle
    • FoodTech
    • Beauty & Fashion
    • Wellbeing
    • Arts & Music
    • Anime
  • Travel
    • Adventure Travel
    • Luxury Travel
    • Wellness & Medical Tourism
    • Culture
  • Video
  • Deals
    • Venture Capital
    • M&A
    • Events
    • Pitch
    • Growth Support
    • Legal & IP
  • Interview
  • Opinion
  • Home
  • AI
    • Artificial Intelligence
    • Robotics
    • Mobility
    • FinTech
    • Quantum
  • Earth
    • AgriTech
    • Green Innovation
    • Disaster Tech
    • SpaceTech
    • Materials
  • Life Sciences
    • BioTech
    • HealthTech
    • MedTech
    • AgeTech
  • Society
    • Media
    • EdTech
    • Diversity
    • FemTech
    • Social Impact
  • Lifestyle
    • FoodTech
    • Beauty & Fashion
    • Wellbeing
    • Arts & Music
    • Anime
  • Travel
    • Adventure Travel
    • Luxury Travel
    • Wellness & Medical Tourism
    • Culture
  • Video
  • Deals
    • Venture Capital
    • M&A
    • Events
    • Pitch
    • Growth Support
    • Legal & IP
  • Interview
  • Opinion
en English ja 日本語 zh 中文 (中国)
JStories
No Result
View All Result

IRIS Optronics Unveils Ultra-High Reflectance Full-Color Cholesteric Liquid Crystal E-Paper and Novel Human-Machine Interface Display Integrating Palm Vein Pattern Recognition​PR Newswire

PR Newswire by PR Newswire
04/16/2026
in PRESS RELEASE
0
Home PRESS RELEASE
Share on FacebookShare on Twitter

​TAINAN, April 16, 2026 /PRNewswire/ — IRIS Optronics, a leading innovator in cholesteric liquid crystal (ChLCD) display technology, has unveiled its new breakthroughs: an ultra-high reflectance full-color ChLCD e-Paper and a novel human-machine interface display integrating infrared palm vein pattern recognition. IRIS Optronics Introduces a New Human-Machine Interface Integrated with Palm Vein Recognition, While Advancing Its Technology to Boost ChLCD e-Paper Reflectance Beyond 50% (Photo shows Dr. Albert Liao, Chairman & CEO of IRIS Optronics) These innovations mark a significant expansion of ChLCD-based applications and were showcased at the recently concluded Touch Taiwan 2026 exhibition, where they received strong interest from multiple industry partners. In particular, the high-reflectance full-color e-Paper attracted significant attention, while the palm vein recognition-enabled interface demonstrated a new direction for secure and intelligent display applications, underscoring IRIS Optronics’ continuous innovation momentum. Breakthrough in Full-Color ChLCD Reflectance Exceeding 50% “Full-color ChLCD e-Paper represents a rapidly emerging opportunity in the display industry. The company has continued to advance its ChLCD technology, successfully increasing display reflectance to over 50%,” said Dr. Albert Liao, Chairman of IRIS Optronics. “Through precise material optimization and chirality engineering, the e-Paper fully utilizes ambient light, significantly enhancing brightness, color saturation, and readability under low-light conditions such as indoor environments, adverse weather, or dawn and dusk scenarios. This breakthrough not only improves visual performance but also expands the applicability of e-Paper in outdoor and energy-sensitive environments, opening new opportunities for sustainable display solutions.” ChLCD Integrated Palm Vein Recognition for Next-Generation Secure Interaction Building on its proprietary full-color ChLCD platform, IRIS Optronics has introduced a new generation of human-machine interface integrating infrared palm vein pattern recognition technology. The system retains the bistable, low-power characteristics of e-Paper while leveraging the light-transmissive properties of ChLCD to integrate infrared sensing capabilities developed in collaboration with Himax Technologies. Palm vein biometrics utilize unique vascular patterns beneath the skin. When infrared light is emitted through the display toward the palm, deoxygenated hemoglobin in venous blood absorbs the infrared signal, enabling the system to capture a distinct vascular pattern image for identity verification. Compared with conventional biometric methods such as fingerprint or facial recognition, palm vein patterns are extremely difficult to forge, offering a significantly higher level of security and reliability. Once identity is verified, the system enables personalized content delivery, making it suitable for applications ranging from smart city public displays and targeted advertising to secure access control in private venues such as members-only clubs and facilities. Advancing Smart Displays Through Integrated Ecosystem Collaboration By integrating supply chain partners and cross-domain technologies, IRIS Optronics continues to enhance the security, energy efficiency, and intelligence of its human-machine interface solutions. The company aims to deliver more precise and sustainable smart display technologies, positioning itself as a key enabler of next-generation AI-driven interactive display applications. [About IRIS Optronics] Founded in 2012 in Tainan, Taiwan, IRIS Optronics develops proprietary full-color ChLCD e-Paper technology. The company delivers ultra-wide color gamut displays, advanced optoelectronic integration solutions, and modular large-format systems. Its applications span transportation, healthcare, retail, lifestyle, art, and education—helping cities and industries transition toward sustainable “green display” solutions. Guided by its core values—Integrity, Responsibility, Innovation, and Sharing—IRIS Optronics is building a global e-Paper ecosystem, empowering partners across materials, equipment, IC design, and system integration to drive both commercial success and ESG impact. ​TAINAN, April 16, 2026 /PRNewswire/ — IRIS Optronics, a leading innovator in cholesteric liquid crystal (ChLCD) display technology, has unveiled its new breakthroughs: an ultra-high reflectance full-color ChLCD e-Paper and a novel human-machine interface display integrating infrared palm vein pattern recognition. IRIS Optronics Introduces a New Human-Machine Interface Integrated with Palm Vein Recognition, While Advancing Its Technology to Boost ChLCD e-Paper Reflectance Beyond 50% (Photo shows Dr. Albert Liao, Chairman & CEO of IRIS Optronics) These innovations mark a significant expansion of ChLCD-based applications and were showcased at the recently concluded Touch Taiwan 2026 exhibition, where they received strong interest from multiple industry partners. In particular, the high-reflectance full-color e-Paper attracted significant attention, while the palm vein recognition-enabled interface demonstrated a new direction for secure and intelligent display applications, underscoring IRIS Optronics’ continuous innovation momentum. Breakthrough in Full-Color ChLCD Reflectance Exceeding 50% “Full-color ChLCD e-Paper represents a rapidly emerging opportunity in the display industry. The company has continued to advance its ChLCD technology, successfully increasing display reflectance to over 50%,” said Dr. Albert Liao, Chairman of IRIS Optronics. “Through precise material optimization and chirality engineering, the e-Paper fully utilizes ambient light, significantly enhancing brightness, color saturation, and readability under low-light conditions such as indoor environments, adverse weather, or dawn and dusk scenarios. This breakthrough not only improves visual performance but also expands the applicability of e-Paper in outdoor and energy-sensitive environments, opening new opportunities for sustainable display solutions.” ChLCD Integrated Palm Vein Recognition for Next-Generation Secure Interaction Building on its proprietary full-color ChLCD platform, IRIS Optronics has introduced a new generation of human-machine interface integrating infrared palm vein pattern recognition technology. The system retains the bistable, low-power characteristics of e-Paper while leveraging the light-transmissive properties of ChLCD to integrate infrared sensing capabilities developed in collaboration with Himax Technologies. Palm vein biometrics utilize unique vascular patterns beneath the skin. When infrared light is emitted through the display toward the palm, deoxygenated hemoglobin in venous blood absorbs the infrared signal, enabling the system to capture a distinct vascular pattern image for identity verification. Compared with conventional biometric methods such as fingerprint or facial recognition, palm vein patterns are extremely difficult to forge, offering a significantly higher level of security and reliability. Once identity is verified, the system enables personalized content delivery, making it suitable for applications ranging from smart city public displays and targeted advertising to secure access control in private venues such as members-only clubs and facilities. Advancing Smart Displays Through Integrated Ecosystem Collaboration By integrating supply chain partners and cross-domain technologies, IRIS Optronics continues to enhance the security, energy efficiency, and intelligence of its human-machine interface solutions. The company aims to deliver more precise and sustainable smart display technologies, positioning itself as a key enabler of next-generation AI-driven interactive display applications. [About IRIS Optronics] Founded in 2012 in Tainan, Taiwan, IRIS Optronics develops proprietary full-color ChLCD e-Paper technology. The company delivers ultra-wide color gamut displays, advanced optoelectronic integration solutions, and modular large-format systems. Its applications span transportation, healthcare, retail, lifestyle, art, and education—helping cities and industries transition toward sustainable “green display” solutions. Guided by its core values—Integrity, Responsibility, Innovation, and Sharing—IRIS Optronics is building a global e-Paper ecosystem, empowering partners across materials, equipment, IC design, and system integration to drive both commercial success and ESG impact. 

Previous Post

Sigenergy Successfully Listed on HKEX with Strong Backing from Top-Tier Global Investors​PR Newswire

Next Post

Alumni Gift to SMU Fuels Next Generation of Entrepreneurs​PR Newswire

PR Newswire

PR Newswire

Related Posts

PRESS RELEASE

GOODYEAR ELEVATES 3RD ANNUAL DREAM SUMMER CAMP PROGRAM IN YUNNAN

by PR-Newswire
04/17/2026
PRESS RELEASE

Keelung Welcomes You! FUN KEELUNG for Cruise Crew Tourism at the Port of Keelung Officially Launches

by PR-Newswire
04/17/2026
PRESS RELEASE

Agoda's Top Picks for Birdwatching Destinations Across Asia

by PR-Newswire
04/17/2026
PRESS RELEASE

Breaking the Sourcing Ceiling: APES 2026 Shanghai Unlocks Unfiltered Access to China's Premier Auto Parts Factories

by PR-Newswire
04/17/2026
PRESS RELEASE

Instant Khao Lam (Glutinous Rice in Bamboo Cylinders), a local souvenir that can now be enjoyed internationally

by PR-Newswire
04/17/2026
Next Post

Alumni Gift to SMU Fuels Next Generation of Entrepreneurs​PR Newswire

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Trending

Greening the desert with trash

by Yui Sawada
03/23/2023
0

J-STORIES - The sight of local Niger women throwing kitchen waste out into the African desert inspired a project that...

世界が渇望する日本発バイオ素材、2026年6月以降に市場投入へ

Evolutionary artificial protein slated for market debut as early as June 2026

by Yoshiko Ohira
04/17/2026
0

JStories — Severe and hard-to-heal wounds — such as those caused by burns, injuries, pressure ulcers, skin cancer surgery, and...

INTERVIEW | How Japanese musician Grover turned his passion of ‘sound’ into a health-tech startup

by Toshi Maeda
05/02/2025
0

JStories ー For over two decades, Yoshikazu Grover — better known simply as Grover — has been a familiar voice...

World-first “anime character-based therapy” trial to test effectiveness in Japanese young adults

by Lucas Maltzman
01/30/2026
0

JStories – Is sharing personal problems with a virtual anime character easier than face-to-face? In the world’s first clinical trial,...

World’s first ‘teething drug’ clinical trial starts in September – Aiming for full commercialization by 2030

by Ruriko Kokubun
06/07/2024
0

Editor's Note: This article has been updated with new information. It was originally published on 09/22/2023. J-STORIES - The conventional...

JStories

©Articles and photos published on JStories are protected by Japanese copyright law and international treaties. They cannot be reproduced without the permission of the copyright holders

Explore JStories

  • Home
  • About JStories
  • Company
  • Team
  • Contact
  • Privacy Policy
  • Partner Press Releases

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • AI
    • Artificial Intelligence
    • Robotics
    • Mobility
    • FinTech
    • Quantum
  • Earth
    • AgriTech
    • Green Innovation
    • Disaster Tech
    • SpaceTech
    • Materials
  • Life Sciences
    • BioTech
    • HealthTech
    • MedTech
    • AgeTech
  • Society
    • Media
    • EdTech
    • Diversity
    • FemTech
    • Social Impact
  • Lifestyle
    • FoodTech
    • Beauty & Fashion
    • Wellbeing
    • Arts & Music
    • Anime
  • Travel
    • Adventure Travel
    • Luxury Travel
    • Wellness & Medical Tourism
    • Culture
  • Video
  • Deals
    • Venture Capital
    • M&A
    • Events
    • Growth Support
    • Legal & IP
  • Interview
  • Opinion

©Articles and photos published on JStories are protected by Japanese copyright law and international treaties. They cannot be reproduced without the permission of the copyright holders

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?